Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN)

Clinical trial NCT06962371 · RECRUITING

Trial details

NCT number: NCT06962371
Sponsor: Transverse Medical, Inc.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Transcatheter Aortic Valve Implantation (TAVI)Aortic Valve Stenosis Transcatheter Aortic Valve Replacement

Start date: 2025-04-07
Primary completion: 2026-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.